/PRNewswire/ BioMatrix Specialty Pharmacy announced today that the Board of Directors has appointed Kathee Kramm as Chief Executive Officer, succeeding Nick.
SERB Pharmaceuticals acquires Vistogard® and Xuriden® from Wellstat Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ BioMatrix Specialty Pharmacy announced today Kathee Kramm has joined the executive leadership team as President and Chief Operating Officer..
/PRNewswire/ BioCare, Inc., specializing in delivering specialty and therapeutic biological products since 1982, has named two healthcare industry veterans.